Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed and/or Refractory Mature T Cell Malignancy

Clinical trial condition

Relapsed and/or Refractory Mature T Cell Malignancy

Explore clinical trials studying Relapsed and/or Refractory Mature T Cell Malignancy. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed and/or Refractory Mature T Cell Malignancy trial results

Recruiting

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

NCT07055477

Conditions: Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous T-Cell Lymphoma, +23 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details